東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Pharmacological and Immunological Co...

Schramm, Nathaniel.

Linked to FindBook

Google Book

Amazon

博客來

Pharmacological and Immunological Control of Zika Virus in Mice Deficient in Adaptive Immune Responses.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Pharmacological and Immunological Control of Zika Virus in Mice Deficient in Adaptive Immune Responses./
Author:	Schramm, Nathaniel.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2019,
Description:	68 p.
Notes:	Source: Masters Abstracts International, Volume: 80-12.
Contained By:	Masters Abstracts International80-12.
Subject:	Pharmacology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13859162
ISBN:	9781392203590

Pharmacological and Immunological Control of Zika Virus in Mice Deficient in Adaptive Immune Responses.
Schramm, Nathaniel.

Pharmacological and Immunological Control of Zika Virus in Mice Deficient in Adaptive Immune Responses. - Ann Arbor : ProQuest Dissertations & Theses, 2019 - 68 p.

Source: Masters Abstracts International, Volume: 80-12.

Thesis (M.S.)--The University of North Carolina at Chapel Hill, 2019.

This item must not be sold to any third party vendors.

Zika virus (ZIKV) has recently demonstrated epidemic potential with prolonged infection, sexual and mother to fetus transmission, severe clinical manifestation of fetal microcephaly and congenital malformations and Guillain-Barre syndrome in adults. Existing small animal models for ZIKV infection based on interferon (IFN)-deficient mice are not well suited for long-term assessment of therapeutics. Here, we show that in contrast to immunocompetent mice that control ZIKV infection and IFN-deficient mice that rapidly succumb to infection, immunodeficient mouse strains lacking T, B, and NK cells support systemic ZIKV replication for long periods of time. Using these immunodeficient mice, we evaluated the efficacy of 7-Deaza-7-fluoro-2'-C-methyl-adenoside (DFMA), a small molecular inhibitor and a neutralizing antibody (C10) to suppress systemic ZIKV replication in vivo. DFMA treatment resulted in efficient and sustained viral suppression. Treatment with C10 also resulted in viral suppression in highly clinically relevant tissues like the brain, eyes, gastrointestinal tract, and male and female reproductive organs.

ISBN: 9781392203590Subjects--Topical Terms:

634543
Pharmacology.

Pharmacological and Immunological Control of Zika Virus in Mice Deficient in Adaptive Immune Responses.
LDR:02322nmm a2200373 4500 001 2207290
005 20190916101815.5
008 201008s2019 ||||||||||||||||| ||eng d
020 $a 9781392203590
035 $a (MiAaPQ)AAI13859162
035 $a (MiAaPQ)unc:18601
035 $a AAI13859162
040 $a MiAaPQ $c MiAaPQ
100 1 $a Schramm, Nathaniel. $3 3434263
245 1 0 $a Pharmacological and Immunological Control of Zika Virus in Mice Deficient in Adaptive Immune Responses.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2019
300 $a 68 p.
500 $a Source: Masters Abstracts International, Volume: 80-12.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Garcia-Martinez, J Victor;Baric, Ralph.
502 $a Thesis (M.S.)--The University of North Carolina at Chapel Hill, 2019.
506 $a This item must not be sold to any third party vendors.
520 $a Zika virus (ZIKV) has recently demonstrated epidemic potential with prolonged infection, sexual and mother to fetus transmission, severe clinical manifestation of fetal microcephaly and congenital malformations and Guillain-Barre syndrome in adults. Existing small animal models for ZIKV infection based on interferon (IFN)-deficient mice are not well suited for long-term assessment of therapeutics. Here, we show that in contrast to immunocompetent mice that control ZIKV infection and IFN-deficient mice that rapidly succumb to infection, immunodeficient mouse strains lacking T, B, and NK cells support systemic ZIKV replication for long periods of time. Using these immunodeficient mice, we evaluated the efficacy of 7-Deaza-7-fluoro-2'-C-methyl-adenoside (DFMA), a small molecular inhibitor and a neutralizing antibody (C10) to suppress systemic ZIKV replication in vivo. DFMA treatment resulted in efficient and sustained viral suppression. Treatment with C10 also resulted in viral suppression in highly clinically relevant tissues like the brain, eyes, gastrointestinal tract, and male and female reproductive organs.
590 $a School code: 0153.
650 4 $a Pharmacology. $3 634543
650 4 $a Health sciences. $3 3168359
650 4 $a Public health. $3 534748
650 4 $a Physiology. $3 518431
650 4 $a Virology. $3 642304
650 4 $a Immunology. $3 611031
690 $a 0419
690 $a 0566
690 $a 0573
690 $a 0719
690 $a 0720
690 $a 0982
710 2 $a The University of North Carolina at Chapel Hill. $b Microbiology and Immunology. $3 3182993
773 0 $t Masters Abstracts International $g 80-12.
790 $a 0153
791 $a M.S.
792 $a 2019
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=13859162